For the first time in the UAE .. “Burjeel Medical” provides an innovative treatment for a rare life disease

Under the supervision of the Department of Health – Abu Dhabi, the Burjeel Medical City in Abu Dhabi provided for the first time in the UAE, an innovative treatment for a rare genetic disorder that leads to the accumulation of toxic interlocutors in the liver, where a 21 -year -old young citizen, whose name is Muhammad, was diagnosed with severe porfiria, intermittent hepatitis (AIP ), A rare condition that affects only five people out of every million people.

Mohamed was the first patient in the country to be treated with “Guevosiran” in the medical city of Burjil. The infection of this rare hepatic disease occurs, due to a genetic defect in one of the enzymes that causes the accumulation of toxic swaps in the liver, as it leads to the emergence of symptoms such as severe abdominal pain, nausea, vomiting, tremors, peripheral neuropathy, nervous and psychological disorders, and other possible complications that may threaten life, such as failure Ruby, liver function, paralysis and liver cancer.

Dr. Asmaa Al -Mannai, Executive Director of the Health Life Sciences Sector in the Health Department – Abu Dhabi said: “We continue in Abu Dhabi our commitment to ensure the provision of health care at the highest levels of quality and enhance the health and well -being of community members in the emirate, by providing the latest technologies and advanced and innovative treatments for patients. These accomplishments of Abu Dhabi confirm the efforts made by various partners and stakeholders within the health care system to consolidate the position of Abu Dhabi as a leading destination for health care globally.

Al -Mannai pointed out that the Department of Health – Abu Dhabi worked to codish the drug and document it with an introductory code, after a multi -specialized team at the Research and Innovation Center conducted a comprehensive evaluation of its effectiveness, allowing health facilities in the emirate to provide the drug efficiently, ensuring its coverage within the health insurance network, and facilitates obtaining obtaining Treatment.

Approved drug in the state

“The case of Muhammad is a milestone in the treatment of rare diseases in the UAE, as the drug (Guevosiran) has become officially available on the list of drugs accredited in the country, which prepares the way to treat patients with it.

This condition shows the ingenuity of doctors in the medical city of Burjal, in the treatment of rare diseases and complex care, especially since the symptoms of some genetic diseases are not common, but in light of the presence of a high level of experience and deep medical thinking, the symbols of some rare medical conditions can be deciphered.

Muhammad’s mother said: “My son suffered from a rare health condition for years, as the pain was severe abdomen, constant fatigue, weight loss and repeated treatment in the hospital destroyed for us and his and our meeting with Dr. Khaled in the medical city The correct diagnosis, and I thank the Health Department – Abu Dhabi, which contributed to providing treatment for my son during a time Standard. ”

She added, “After Muhammad received the first dose of Jevosiran, we noticed that his pain seizures have decreased a lot, we thank our wise leadership for its support in providing modern treatments, and we thank the dedicated medical team in Burjeel Medical City.”

It is noteworthy that the medical team in Burjeel Medical City is still following the case of Muhammad, which prevails with good and recovery according to the initial indicators, in the hope that the drug (Gevosiran) will significantly improve the quality of his life, and prevent other complications.

The clinical study of the Envyngen Group for Medical Services showed the effectiveness of the new Gevosiran drug, as it recorded a decrease of 74% in the annual seizures rates, a 90% decrease in the levels of aminovolinic acid and Purvopylinogen, and a significant improvement in the quality of patients ’life.